Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
CN |
|
Dnxcorp Se
PAR:ALDNX
|
LU |
|
M
|
Minshang Creative Technology Holdings Ltd
HKEX:1632
|
HK |
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
JP |
|
Town Health International Medical Group Ltd
HKEX:3886
|
HK |
|
I
|
Insight Digital Partners II
NASDAQ:DYOR
|
US |
|
Electronic City Indonesia Tbk PT
IDX:ECII
|
ID |
|
Randon SA Implementos e Participacoes
BOVESPA:RAPT4
|
BR |
Wall Street
Price Targets
Price Targets Summary
Hansoh Pharmaceutical Group Company Ltd
According to Wall Street analysts, the average 1-year price target for Hansoh Pharmaceutical Group Company Ltd is 46.1 HKD with a low forecast of 37.84 HKD and a high forecast of 54.08 HKD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Hansoh Pharmaceutical Group Company Ltd's stock price target?
Price Target
46.1
HKD
According to Wall Street analysts, the average 1-year price target for Hansoh Pharmaceutical Group Company Ltd is 46.1 HKD with a low forecast of 37.84 HKD and a high forecast of 54.08 HKD.
What is Hansoh Pharmaceutical Group Company Ltd's Revenue forecast?
Projected CAGR
12%
For the last 8 years the compound annual growth rate for Hansoh Pharmaceutical Group Company Ltd's revenue is 12%. The projected CAGR for the next 3 years is 12%.
What is Hansoh Pharmaceutical Group Company Ltd's Operating Income forecast?
Projected CAGR
8%
For the last 8 years the compound annual growth rate for Hansoh Pharmaceutical Group Company Ltd's operating income is 17%. The projected CAGR for the next 3 years is 8%.
What is Hansoh Pharmaceutical Group Company Ltd's Net Income forecast?
Projected CAGR
18%
For the last 8 years the compound annual growth rate for Hansoh Pharmaceutical Group Company Ltd's net income is 17%. The projected CAGR for the next 3 years is 18%.
